Total Payments
$56,168
2023 Payments
$749.00
Companies
8
Transactions
57
Payment Breakdown by Category
Consulting$50,083 (89.2%)
Travel$4,567 (8.1%)
Food & Beverage$1,421 (2.5%)
Research$97.20 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $50,083 | 11 | 89.2% |
| Travel and Lodging | $4,567 | 19 | 8.1% |
| Food and Beverage | $1,421 | 26 | 2.5% |
| Unspecified | $97.20 | 1 | 0.2% |
Payments by Type
General
$56,071
56 transactions
Research
$97.20
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $25,590 | 22 | $0 (2022) |
| Partner Therapeutics, Inc. | $9,014 | 9 | $0 (2018) |
| Incyte Corporation | $7,835 | 12 | $0 (2017) |
| Millennium Pharmaceuticals, Inc. | $6,295 | 7 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $5,123 | 2 | $0 (2023) |
| Mallinckrodt LLC | $2,000 | 1 | $0 (2017) |
| BeiGene USA, Inc. | $183.51 | 1 | $0 (2022) |
| Celgene Corporation | $128.06 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $749.00 | 1 | SANOFI-AVENTIS U.S. LLC ($749.00) |
| 2022 | $7,324 | 3 | E.R. Squibb & Sons, L.L.C. ($7,140) |
| 2021 | $4,374 | 1 | SANOFI-AVENTIS U.S. LLC ($4,374) |
| 2019 | $12,259 | 9 | E.R. Squibb & Sons, L.L.C. ($12,259) |
| 2018 | $9,225 | 14 | Partner Therapeutics, Inc. ($9,014) |
| 2017 | $22,237 | 29 | Incyte Corporation ($7,835) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2023 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Consulting Fee | Cash or cash equivalent | $749.00 | General |
| Category: Oncology | ||||||
| 04/23/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $183.51 | General |
| Category: Oncology | ||||||
| 01/04/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,570.00 | General |
| 01/04/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,570.00 | General |
| 06/28/2021 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Consulting Fee | Cash or cash equivalent | $4,374.00 | General |
| Category: Oncology | ||||||
| 10/04/2019 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $10,800.00 | General |
| 08/23/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $29.31 | General |
| Category: Oncology | ||||||
| 08/23/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.96 | General |
| Category: Oncology | ||||||
| 08/21/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $335.18 | General |
| Category: Oncology | ||||||
| 08/21/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $291.42 | General |
| Category: Oncology | ||||||
| 08/20/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $183.40 | General |
| Category: Oncology | ||||||
| 06/16/2019 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $260.78 | General |
| 06/16/2019 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $233.93 | General |
| 06/16/2019 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $102.29 | General |
| 12/20/2018 | Partner Therapeutics, Inc. | Leukine (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Hematology | ||||||
| 11/30/2018 | Partner Therapeutics, Inc. | Leukine (Drug) | Food and Beverage | In-kind items and services | $68.00 | General |
| Category: Hematology | ||||||
| 11/30/2018 | Partner Therapeutics, Inc. | Leukine (Drug) | Food and Beverage | In-kind items and services | $36.00 | General |
| Category: Hematology | ||||||
| 11/30/2018 | Partner Therapeutics, Inc. | Leukine (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Hematology | ||||||
| 11/16/2018 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $53.05 | General |
| Category: Immunology | ||||||
| 11/16/2018 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $28.57 | General |
| Category: Immunology | ||||||
| 11/16/2018 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $26.51 | General |
| Category: Immunology | ||||||
| 11/16/2018 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $26.51 | General |
| Category: Immunology | ||||||
| 11/15/2018 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Travel and Lodging | Cash or cash equivalent | $76.15 | General |
| Category: Immunology | ||||||
| 04/28/2018 | Partner Therapeutics, Inc. | Leukine (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Hematology | ||||||
| 04/28/2018 | Partner Therapeutics, Inc. | Leukine (Drug) | Travel and Lodging | Cash or cash equivalent | $457.60 | General |
| Category: Hematology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) | Millennium Pharmaceuticals, Inc. | $97.20 | 1 |
About Dr. Steven Devine, M.D
Dr. Steven Devine, M.D is a Medical Oncology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124036579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Devine, M.D has received a total of $56,168 in payments from pharmaceutical and medical device companies, with $749.00 received in 2023. These payments were reported across 57 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($50,083).
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Hematology
- Location Columbus, OH
- Active Since 08/03/2006
- Last Updated 04/26/2012
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1124036579
Products in Payments
- Leukine (Drug) $9,014
- JAKAFI (Drug) $7,835
- ENTYVIO (Biological) $6,295
- ORENCIA (Biological) $6,190
- THYMOGLOBULIN (Biological) $5,123
- UVADEX (METHOXSALEN) STERILE SOLUTION (Drug) $2,000
- OPDIVO (Biological) $862.27
- BRUKINSA (Drug) $183.51
- Idhifa (Drug) $11.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Columbus
Taral Patel, Md, MD
Medical Oncology — Payments: $826,872
Medical Oncology $826,872
Tarek Chidiac, Md, MD
Medical Oncology — Payments: $800,968
Medical Oncology $800,968
Robert Wesolowski, Md, MD
Medical Oncology — Payments: $281,784
Medical Oncology $281,784
Dr. Christian Rolfo, Md, MD
Medical Oncology — Payments: $235,782
Medical Oncology $235,782
Yuanquan Yang, M.d, M.D
Medical Oncology — Payments: $111,221
Medical Oncology $111,221
Dr. Timothy Burns, M.d. Ph.d, M.D. PH.D
Medical Oncology — Payments: $109,695
Medical Oncology $109,695